Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleEndocrine and Diabetes

LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice

David R. Powell, Melinda G. Smith, Deon D. Doree, Angela L. Harris, Jennifer Greer, Christopher M. DaCosta, Andrea Thompson, Sabrina Jeter-Jones, Wendy Xiong, Kenneth G. Carson, Nicole C. Goodwin, Bryce A. Harrison, David B. Rawlins, Eric D. Strobel, Suma Gopinathan, Alan Wilson, Faika Mseeh, Brian Zambrowicz and Zhi-Ming Ding
Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 85-97; DOI: https://doi.org/10.1124/jpet.117.240820
David R. Powell
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melinda G. Smith
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deon D. Doree
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela L. Harris
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Greer
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. DaCosta
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Thompson
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina Jeter-Jones
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Xiong
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth G. Carson
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole C. Goodwin
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryce A. Harrison
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David B. Rawlins
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric D. Strobel
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suma Gopinathan
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Wilson
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faika Mseeh
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Zambrowicz
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi-Ming Ding
Lexicon Pharmaceuticals, Inc., The Woodlands, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 362 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 362, Issue 1
1 Jul 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleEndocrine and Diabetes

LX2761 Improves Glycemic Control

David R. Powell, Melinda G. Smith, Deon D. Doree, Angela L. Harris, Jennifer Greer, Christopher M. DaCosta, Andrea Thompson, Sabrina Jeter-Jones, Wendy Xiong, Kenneth G. Carson, Nicole C. Goodwin, Bryce A. Harrison, David B. Rawlins, Eric D. Strobel, Suma Gopinathan, Alan Wilson, Faika Mseeh, Brian Zambrowicz and Zhi-Ming Ding
Journal of Pharmacology and Experimental Therapeutics July 1, 2017, 362 (1) 85-97; DOI: https://doi.org/10.1124/jpet.117.240820

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleEndocrine and Diabetes

LX2761 Improves Glycemic Control

David R. Powell, Melinda G. Smith, Deon D. Doree, Angela L. Harris, Jennifer Greer, Christopher M. DaCosta, Andrea Thompson, Sabrina Jeter-Jones, Wendy Xiong, Kenneth G. Carson, Nicole C. Goodwin, Bryce A. Harrison, David B. Rawlins, Eric D. Strobel, Suma Gopinathan, Alan Wilson, Faika Mseeh, Brian Zambrowicz and Zhi-Ming Ding
Journal of Pharmacology and Experimental Therapeutics July 1, 2017, 362 (1) 85-97; DOI: https://doi.org/10.1124/jpet.117.240820
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A Novel Polymeric Sequestrant Delays Diabetic Nephropathy
  • NMDA Receptor Antagonists and β-Cells
  • The Roles of Oleoylethanolamide in Hepatic Glycometabolism
Show more Endocrine and Diabetes

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics